Biotechnology

Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS

EMA accelerated assessment allows a shorter review period for leniolisib from a standard 210 days to 150 days Pharming is on track to submit its Marketing Authorisation Application for leniolisib in H2 2022 LEIDEN, the Netherlands, Aug. 1, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or...

2022-08-01 13:00 2689

NeuroXess made the list of MIT Technology Review's TR50 for its silk-based minimally invasive implantable flexible brain-machine interface technology

WUXI, China, Aug. 1, 2022 /PRNewswire/ -- NeuroXess announced that it has been included in MIT Technology Review's list of the world's 50 smartest companies – the TR50 list – released onJuly 29 in Wuxi, China. NeuoXess was recognized mainly for its silk-enabled minimally invasive implantable high...

2022-08-01 12:40 2036

Active Motif and EpiCypher Execute Cross-Licensing Agreement and End Ongoing Litigation Involving Targeted Transposition/CUT&Tag Technology for Epigenomics

CARLSBAD, Calif. and RESEARCH TRIANGLE PARK, N.C., Aug. 1, 2022 /PRNewswire/ -- CUT&Tag is a targeted transposition technique that allows high-resolution genomic mapping of histone modifications and chromatin-associated proteins through the precise insertion of DNA sequences into the genome using...

2022-08-01 12:01 1749

Active Motif Incorporated Licenses Targeted Transposition to Diagenode S.A. Technology

CARLSBAD, Calif., Aug. 1, 2022 /PRNewswire/ -- Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has non-exclusively licensed its foundational patents in transposition for use in CUT&Tag epigenetic assays to Diageno...

2022-08-01 11:30 1898

Innovent and Laekna Jointly Announce First Patient Dosed with Three-drug Combination in a Phase 1/2 Study for the Treatment of Patients with Solid Tumors Who Were Resistant to Prior Anti-PD-1/PD-L1 Therapy

SAN FRANCISCO and SUZHOU, China, Aug. 1, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and ot...

2022-08-01 08:00 2691

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started

Concept Medical Inc. , a pioneer in developing drug delivery device platforms for vascular intervention, has announced the initiation of LIMES trial. MÜNSTER, Germany, July 29, 2022 /PRNewswire/ -- LIMES (Prospective Multi-Center Randomized Controlled Trial to Ev...

2022-07-29 20:56 5751

HanAll Biopharma Reports Second Quarter 2022 Results and Provides Business Update

* Financial performance for Q2 2022 records revenues of KRW 26.2 billion, a 12% growth from the same period last year, driven by strong sales performance from the pharmaceutical division   * Operating income turned to profit compared to the last quarter, while investment to R&D continued in t...

2022-07-29 20:00 2955

As part of 'Operation Nasal Vaccine' to counter COVID-19 spread, ACM-001 booster vaccine administered to first subject in phase 1 safety and immunogenicity trial

SINGAPORE and BASEL, Switzerland and SYDNEY, July 29, 2022 /PRNewswire/ -- ACM Biolabs , a biotechnology company with operations in Singapore, Switzerland and Australia, focusing on the development of next generation vaccines for infectious diseases, personalized immunoth...

2022-07-29 16:00 2206

ZAODX World Conference on Early Detection of Cancer was successfully held in Guangzhou, China

GUANGZHOU, China, July 29, 2022 /PRNewswire/ -- The inaugural ZAODX World Conference on Early Detection of Cancer ("the Conference") was successfully held at the Chimelong International Conference Center inGuangzhou from July 15-17, 2022. In attendance were founders and representatives from over ...

2022-07-29 15:35 1516

Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects

The Universal Antibody Lock technology will give patients more of a choice TAIPEI, July 29, 2022 /PRNewswire/ -- PrecisemAb Biotech , a biotechnology research company based in Kaohsiung,Taiwan, continues to stay true to its vision of enhancing antibody drugs b...

2022-07-29 12:09 1491

The Taiwanese Startup Mindtronic AI Opens the Way to the Future of Mobility With Meta-Service Ecosystem

The Taiwanese start-up marks its fifth CES Innovation Award win since 2018 with its auto technology. LAS VEGAS, July 29, 2022 /PRNewswire/ -- Mindtronic AI ( https://www.mindtronicai.com/ ), a Taiwan-based startup, unveils the world's first Meta-Service, a biometric...

2022-07-29 12:01 1653

Angel Yeast Showcases Latest Innovation in Fermentation Nutrients at Bio China 2022

JINAN, China, July 28, 2022 /PRNewswire/ -- Angel Yeast (SH600298), a globally listed yeast and yeast extract manufacturer, exhibited its latest products and solutions of fermentation nutrients at Bio China 2022, an expo on fermentation and biotechnology held inJinan...

2022-07-28 20:48 3699

Ubiquitome's Liberty16 Pro ready to carve up next COVID wave

Faster mobile PCR test device helping business continuity CHICAGO, July 28, 2022 /PRNewswire/ -- Ubiquitome , which won through the United States' NIH RADx shark tank

2022-07-28 20:39 1867

ILC Dover Announces Multi-compendial Water for Injection (WFI) for Growing Biotherapeutic and Cell & Gene Therapy Markets

NEWARK, Del., July 28, 2022 /PRNewswire/ -- ILC Dover LP ("ILC Dover" or the "Company"), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market. Used for the preparation of...

2022-07-28 20:00 2307

Kira Pharmaceuticals Receives FDA Orphan Drug Designation for KP104, a Bifunctional Antibody Fusion Protein, for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

CAMBRIDGE, Mass. and SUZHOU, China, July 28, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Or...

2022-07-28 19:00 2404

Transcenta to Present Interim Safety and Efficacy Data of the TST001 and Chemotherapy Combination Expansion Cohort for Claudin18.2 Positive First Line Gastric Cancer at ESMO Congress 2022

SUZHOU, China, July 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the interim safe...

2022-07-28 08:00 2122

Plant-Oil-Based Skincare Technology Business Available for License or Purchase

A NEW AND UNIQUE ANHYDROUS SKINCARE TECHNOLOGY OF PROVEN VERY HIGH EFFICACY  AUCKLAND, New Zealand, July 27, 2022 /PRNewswire/ -- Invented and developed by the CEO ofFutecNZ Limited in New Zealand, (trading under the ONE24 brand) trialled and tested by accredited scientific laboratories, a vast t...

2022-07-28 05:22 1493

Origin Agritech Receives a $35 Million Order from Muyuan Foods

Companies Plan to Expand Partnership Significantly Beyond This Initial Order BEIJING, July 27, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that the company has received an order for its hybrid corn worthR...

2022-07-27 23:06 2395

Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis

SHANGHAI, China, July 27, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnovator is committed to being a collaborative platform for Innovative Biotech companies from around the world. Over the past 2 month, its portfolio companies have had great progress. AIxplorerBIO...

2022-07-27 21:30 2257

Noul's Hydrogel Stamping is the potential core technology necessary for precise cancer diagnosis, study confirmed

* The method shows highly efficient and simple on immunostaining  * Research Paper by Biotech Start up Noul, Harvard Medical School, and Massachusetts General Hospital Published on American Chemical Society Applied Materials and Interfaces. YONGIN, South Korea, July 27, 2022 /PRNewswire/ -- A ...

2022-07-27 20:00 2043
1 ... 161162163164165166167 ... 307